GREGORY D. PERRY - 17 Jun 2021 Form 4 Insider Report for Kala Pharmaceuticals, Inc. (KALA)

Role: Director
Signature: /s/ Mary Reumuth, Attorney-in-Fact
Issuer symbol: KALA
Transactions as of: 17 Jun 2021
Net transactions value: $0
Form type: 4
Filing time: 21 Jun 2021, 17:30:57 UTC
Previous filing: 02 Jun 2021
Next filing: 28 Feb 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	KALA	Common Stock	Award	$0	+20,000	+100%	$0.000000	40,000	17 Jun 2021	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Grant of restricted stock units ("RSUs") under the Issuer's 2017 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the reporting person's continued service with the Issuer, the RSUs will vest as to 100% of the shares underlying the RSUs on the earlier of (i) June 17, 2022 or (ii) the date of the first annual meeting following June 17, 2021.
F2	Includes 20,000 unvested RSUs.

Content

Grant of restricted stock units ("RSUs") under the Issuer's 2017 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the reporting person's continued service with the Issuer, the RSUs will vest as to 100% of the shares underlying the RSUs on the earlier of (i) June 17, 2022 or (ii) the date of the first annual meeting following June 17, 2021.

Includes 20,000 unvested RSUs.